Serum/Plasma Proteomics

Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.-  A Protocol for the Preparation of Cryoprecipitate and Cryo-Depleted Plasma.- A Proteomic Protocol for the Preparation of Platelet Concentrates.- Bead-based and Multiplexed Immunoassays for Protein Profiling via Sequential Affinity Capture.- Affinity Proteomics for Fast, Sensitive, Quantitative Analysis of Proteins in Plasma.- Characterization of the Low-molecular Weight Human Plasma Peptidome.- In-depth, Reproducible Analysis of Human Plasma using IgY 14 and SuperMix Immunodepletion.- Low-Molecular-Weight Plasma Proteome Analysis Using Top-Down Mass Spectrometry.- Identification of Post-Translational Modifications from Serum/Plasma by Immunoaffinity Enrichment and LC-MS/MS Analysis without Depletion of Abundant Proteins.- Identification of Core-fucosylated Glycoproteome in Human Plasma.- Proteomic Analysis of Blood Extracellular Vesicles in Cardiovascular Disease by LC-MS/MS Analysis.- Targeted Approach For Proteomic Analysis of a Hidden Membrane Protein.- Red Blood Cells in Clinical Proteomics.- High-throughput Quantitative Lipidomics Analysis of Non-esterified Fatty Acids in Plasma by LC-MS.- Simultaneous Enrichment of Plasma Extracellular Vesicles and Glycoproteome for Studying Disease Biomarkers.- Lipidomics of Human Blood Plasma by High Resolution Shotgun Mass Spectrometry.- Proteomics Analysis of Circulating Serum Exosomes.- High-density Serum/Plasma Reverse Phase Protein Arrays.- Antibody Colocalization Microarray for Cross-reactivity free Multiplexed Protein Analysis.- Surface Profiling of Extracellular Vesicles From Plasma or Ascites Fluid using Dotscan Antibody.- Serum Profiling for Identification of Autoantibody Signatures in Diseases using Protein Microarrays.- Quantitative Comparisons of Large Numbers of Human Plasma Samples using TMT10plex Labelling.- Efficient Quantitative Comparisons of Plasma Proteomes using Label-free Analysis with MaxQuant.- Blood and Plasma Proteomics: Targeted Quantitation and Post-translational Redox Modifications.- SWATH Mass Spectrometry for Proteomics of Non-depleted Plasma.- Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer.- High-throughput Parallel Proteomic Sample Preparation using 96-well Polyvinylidene Fluoride (PVDF) Membranes and C18 Purification Plates.- Targeted Quantification of the Glycated Peptides of Human Serum Albumin.- Absolute Quantification of Middle to High Abundant Plasma Proteins via Targeted Proteomics.- A Highly Automated Shotgun Proteomic Workflow – Clinical Scale and Robustness for Biomarker Discovery in Blood.- Mass Spectrometry-based Serum Proteomics for Biomarker Discovery and Validation.- Metabolomics Towards Biomarker Discovery.- Plasma Biomarker Identification and Quantification by Microparticle Proteomics.- Bronchoalveolar Lavage Quantitative Mass Spectrometry based Proteomics Analysis in Lung Diseases.- Protein Multiplexed Immunoassay Analysis with R.- Appendix I Standard operating procedures for plasma collection in clinical research.- Appendix II Standard operating procedures for serum collection in clinical research.- Appendix III Reference ranges for blood tests.